A Prospective Observational Study of the Clinical Performance of Zarin in Madagascar

FHI 360

Status: Completed

Conditions: Long-term and Permanent Contraceptive Methods

Study type: Observational

Funder types: Other

Identifiers

NCT01200576

10225

Details and patient eligibility

About

This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.

Full description

This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.

Enrollment: 621 patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• be a participant of the MSM service evaluation and continue using Zarin at 3 months
• agree at the time of Zarin insertion to be contacted regarding an opportunity to participate in more research related to the implant

Exclusion criteria

Trial design

621 participants in 1 patient group

1

Description:

healthy volunteers